Skip to main content
Home
FULL MENU Close Menu
Home
Home

HT Staff

News

CMT provides survival benefit in young HL patients

Author:
HT Staff
Publish date: January 4, 2019

Combined modality therapy (CMT) can improve survival in young patients with early stage Hodgkin lymphoma (HL), according to research published in...

  • Read More

News

EC approves split dosing regimen for daratumumab

Author:
HT Staff
Publish date: January 3, 2019

The European Commission (EC) has granted marketing authorization for a split dosing regimen for daratumumab (Darzalex®). The approval provides...

  • Read More

News

Potential treatment on the horizon for cold agglutinin disease

Author:
HT Staff
Publish date: January 2, 2019

In a first-in-human trial, sutimlimab rapidly halted hemolysis, corrected anemia, precluded the need for transfusion, and caused no serious...

  • Read More

News

FDA approves first treatment for BPDCN

Author:
HT Staff
Publish date: December 26, 2018

The U.S.

  • Read More

News

FDA approves ravulizumab for PNH

Author:
HT Staff
Publish date: December 25, 2018

The U.S.

  • Read More

News

FDA approves calaspargase pegol-mknl for ALL

Author:
HT Staff
Publish date: December 24, 2018

The U.S.

  • Read More

News

CHMP recommends treosulfan for allo-HSCT conditioning

Author:
HT Staff
Publish date: December 21, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for treosulfan (Trecondi) as part...

  • Read More

News

CHMP backs lusutrombopag for severe thrombocytopenia

Author:
HT Staff
Publish date: December 21, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for lusutrombopag to treat severe...

  • Read More

News

Long-acting interferon recommended for PV

Author:
HT Staff
Publish date: December 20, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for ropeginterferon alfa-2b (...

  • Read More

News

CHMP backs dasatinib for kids with newly diagnosed ALL

Author:
HT Staff
Publish date: December 19, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the marketing authorization for...

  • Read More

News

Health Canada approves new indication for daratumumab

Author:
HT Staff
Publish date: December 18, 2018

Health Canada has approved a third indication for daratumumab (Darzalex®) in multiple myeloma (MM). The drug is now approved for use in...

  • Read More

News

CHMP recommends BV+AVD for Hodgkin lymphoma

Author:
HT Staff
Publish date: December 18, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the marketing authorization for...

  • Read More

News

Romiplostim now approved for children with ITP

Author:
HT Staff
Publish date: December 15, 2018

The thrombopoietin receptor agonist romiplostim (NPlate®) is now approved by the U.S.

  • Read More

News

Serious side effect of AML treatment going unnoticed, FDA warns

Author:
HT Staff
Publish date: November 30, 2018

The U.S.

  • Read More

News

FDA approves gilteritinib for relapsed/refractory AML

Author:
HT Staff
Publish date: November 29, 2018

The U.S.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close